UNC13B — UNC13 Homolog B (Munc13-2)

📖 Wiki Page

gene2682 wordssynced 2026-04-02

title: UNC13B — UNC13 Homolog B (Munc13-2)
category: gene

UNC13B — UNC13 Homolog B (Munc13-2)

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Munc13-2 (Munc13 Homolog B)</th></tr>
<tr><td>Gene Symbol</td><td>UNC13B</td></tr>
<tr><td>Full Name</td><td>UNC13 Homolog B</td></tr>
<tr><td>Protein Name</td><td>Munc13-2 (Mammalian uncoordinated 13-2)</td></tr>
<tr><td>Chromosome</td><td>9p13.3</td></tr>
<tr><td>NCBI Gene ID</td><td>[23026](https://www.ncbi.nlm.nih.gov/gene/23026)</td></tr>
<tr><td>OMIM</td><td>[607698](https://www.omim.org/entry/607698)</td></tr>
<tr><td>Ensembl ID</td><td>ENSG00000075643</td></tr>
<tr><td>UniProt ID</td><td>[Q9Y5S4](https://www.uniprot.org/uniprot/Q9Y5S4)</td></tr>
<tr><td>Protein Class</td><td>Synaptic vesicle priming protein, C1 domain-containing</td></tr>
<tr><td>Associated Diseases</td><td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), [Epilepsy](/diseases/epilepsy), Schizophrenia</td></tr>
</table>
</div>

Overview

...

title: UNC13B — UNC13 Homolog B (Munc13-2)
category: gene

UNC13B — UNC13 Homolog B (Munc13-2)

Overview

UNC13B encodes Munc13-2 (Mammalian uncoordinated 13-2), a critical presynaptic protein that plays an essential role in neurotransmitter release. Munc13-2 is one of three Munc13 isoforms (Munc13-1, Munc13-2, Munc13-3) that function as master organizers of synaptic vesicle priming, the process that prepares synaptic vesicles for calcium-triggered fusion with the presynaptic membrane.[@varoqueaux2005] Located on chromosome 9p13.3, the UNC13B gene produces multiple protein isoforms through alternative splicing, with the full-length isoform comprising 1,735 amino acids and a molecular weight of approximately 200 kDa.

The discovery of Munc13 proteins emerged from studies in mice, where mutations in the UNC13 gene family were found to cause severe deficits in synaptic transmission. The name "uncoordinated" reflects the phenotypic consequences of Munc13 loss—mice lacking Munc13-1 die shortly after birth due to inability to breathe, while those with reduced Munc13 function exhibit impaired motor coordination. These findings established Munc13 proteins as fundamental components of the synaptic vesicle release machinery.

Beyond its essential role in baseline neurotransmitter release, Munc13-2 is uniquely positioned to modulate synaptic plasticity through its regulation of short-term plasticity, including facilitation and depression.[@stephens2018] The protein's structural features, including a C1 domain that binds diacylglycerol (DAG) and phorbol esters, allow it to integrate synaptic activity signals and adjust release probability accordingly. This plastic regulatory capacity im[@consalez2016]plicates Munc13-2 in cognitive processes including learning and memory, and its dysfunction has been increasingly recognized in neurodegenerative and psychiatric disorders.

Gene Structure and Protein Architecture

Genomic Organization

The UNC13B gene spans approximately 70 kb on chromosome 9p13.3 and comprises 37 exons. The gene exhibits complex alternative splicing that generates multiple isoforms with distinct functional properties:

| Isoform | Structure | Expression Pattern |
|---------|-----------|--------------------|
| Munc13-2 (full-length) | Contains C1, C2B, MUN domain | Ubiquitous, high in cortex |
| Munc13-2B (short) | Lacks C1 domain | Neuron-specific |
| Munc13-2C | Alternative C-terminus | Limited distribution |

The promoter region of UNC13B contains elements responsive to neuronal activity, allowing activity-dependent regulation of expression. Transcription factors including CREB (cAMP response element-binding protein) regulate UNC13B transcription in response to synaptic activity.

Protein Domain Structure

Munc13-2 possesses a multidomain architecture that enables its diverse functions:

Mermaid diagram (expand to render)

MUN domain (Munc13/Necrotic volume): The central MUN domain (approximately 600 amino acids) is the signature feature of Munc13 proteins. This domain mediates oligomerization and is essential for synaptic vesicle priming. Structural studies reveal that the MUN domain resembles the NSF (N-ethylmaleimide-sensitive fusion protein) alpha-SNAP receptor (SNARE) complex-binding region, suggesting a role in SNARE complex assembly.

C1 domain (1-100 aa): The C1 domain binds diacylglycerol (DAG) and phorbol esters, functioning as a lipid sensor. This domain is crucial for the phorbol ester-induced enhancement of neurotransmitter release and allows Munc13-2 to respond to second messenger signaling. The C1 domain is absent in the Munc13-2B isoform, resulting in reduced activity-dependent modulation.

C2B domain (300-400 aa): The C2B domain binds calcium and phospholipids in a manner similar to protein kinase C (PKC) C2 domains. This domain may contribute to vesicle docking or regulate Munc13-2's association with the presynaptic membrane.

**C2C domain (500-600 aa): Another C2 domain with calcium-dependent phospholipid binding activity, potentially involved in membrane interactions during vesicle priming.

C-terminal region (1400-1735 aa): The C-terminus contains binding sites for SNARE proteins and other presynaptic components. This region mediates the functional interaction between Munc13-2 and the synaptic vesicle fusion machinery.

Splice Variants and Functional Implications

The UNC13B gene produces multiple splice variants with distinct functional properties:

Munc13-2 (full-length): Contains all domains including the C1 domain, allowing phorbol ester-responsive regulation
Munc13-2B: Lacks the C1 domain, resulting in reduced activity-dependent modulation
Munc13-2C: Contains alternative C-terminus with potentially different interaction partners

The relative expression of these isoforms varies across brain regions and during development, suggesting isoform-specific functions in different neuronal populations.

Molecular Function in Synaptic Transmission

Synaptic Vesicle Cycle Overview

Neurotransmitter release at chemical synapses proceeds through a series of coordinated steps known as the synaptic vesicle cycle:

Vesicle recycling: Synaptic vesicles are retrieved from the plasma membrane after fusion

Vesicle refilling: Neurotransmitters are loaded into recycled vesicles

Vesicle docking: Docked vesicles are positioned at the active zone

Vesicle priming: Docked vesicles become fusion-competent

Calcium-triggered fusion: Action potential-induced calcium influx triggers fusion

SNARE-mediated fusion: SNARE proteins mediate membrane merger

Munc13-2 plays essential roles in the priming step, without which vesicles cannot undergo calcium-triggered fusion.

Munc13-2 in Synaptic Vesicle Priming

Synaptic vesicle priming refers to the process by which vesicles transition from a docked state to a fusion-competent state that can respond to calcium influx. Munc13 proteins are master regulators of this process:

Mechanisms of priming:

SNARE complex assembly: Munc13-2 facilitates the assembly of the SNARE complex (synaptobrevin/SNAP-25/syntaxin) on synaptic vesicles, a process required for fusion competence

Munc13 oligomerization: Munc13-2 forms oligomers that organize the active zone and create priming sites

Synaptotagmin displacement: Munc13-2 helps position synaptotagmin, the calcium sensor for fusion, in its proper location

Complexin binding: Munc13-2 interacts with complexin, which stabilizes the primed SNARE complex

The essential nature of Munc13-2 in priming is demonstrated by the complete loss of synchronous neurotransmitter release in Munc13-1/Munc13-2 double knockout mice, while partial loss causes severe synaptic deficits.

SNARE Complex Formation

Munc13-2 directly promotes SNARE complex assembly through multiple mechanisms:

Syntaxin recruitment: Munc13-2 helps recruit and organize syntaxin at the active zone
SNARE assembly: The MUN domain facilitates SNARE complex formation
SNARE stabilization: Munc13-2 prevents premature SNARE complex disassembly

This function connects Munc13-2 directly to the core fusion machinery, explaining its essential role in neurotransmitter release.

Regulation by Second Messengers

Munc13-2 is regulated by several second messenger pathways:

| Second Messenger | Effect on Munc13-2 | Functional Consequence |
|------------------|-------------------|----------------------|
| Diacylglycerol (DAG) | C1 domain binding | Enhanced priming |
| Phorbol esters | C1 domain binding | Dramatic release enhancement |
| Calcium | C2B domain binding | Activity-dependent modulation |
| Calmodulin | C-terminal binding | Activity-dependent regulation |

The phorbol ester response is particularly notable—phorbol esters bind to the C1 domain and dramatically enhance neurotransmitter release, demonstrating that Munc13-2 can dynamically modulate synaptic strength in response to signaling pathways.

Expression Patterns and Cellular Localization

Brain Region Distribution

Munc13-2 is expressed throughout the central nervous system with regional variation:

| Brain Region | Expression Level | Cell Types |
|--------------|-------------------|------------|
| Cerebral Cortex | Very High | Layer 2/3 and layer 5 pyramidal neurons |
| Hippocampus | Very High | CA1-CA3 pyramidal neurons, dentate granule cells |
| Cerebellum | High | Purkinje cells, granule cells |
| Striatum | High | Medium spiny neurons |
| Thalamus | Moderate-High | Relay neurons |
| Brainstem | Moderate | Various nuclei |
| Spinal Cord | High | Motor neurons, interneurons |

The high expression in hippocampus and cortex reflects the importance of Munc13-2 in circuits involved in learning and memory.

Cellular and Subcellular Localization

Within neurons, Munc13-2 exhibits presynaptic specialization:

Presynaptic terminals: Highest concentration at synaptic active zones
Active zone membrane: Associated with the electron-dense active zone matrix
Synaptic vesicles: Partially associated with synaptic vesicle pools
Axon initial segment: Lower levels in initial segment
Dendrites: Minimal dendritic localization

The specific localization to presynaptic active zones reflects Munc13-2's essential function in neurotransmitter release at the synapse.

Developmental Expression

Munc13-2 expression changes during development:

Embryonic: Low expression, immature synapses
Early postnatal: Rapid increase as synaptogenesis occurs
Adult: Sustained high expression
Aging: Variable changes, some decrease in aged brain

The developmental profile mirrors the maturation of synaptic transmission, with Munc13-2 levels increasing as functional synapses mature.

Role in Synaptic Plasticity

Short-Term Plasticity

Munc13-2 plays a critical role in regulating short-term synaptic plasticity, the activity-dependent changes in release probability that occur over milliseconds to seconds:

Facilitation: When synapses receive closely spaced stimuli, release probability increases. Munc13-2 contributes to facilitation through:

Residual calcium effects on Munc13-2
Phosphorylation-dependent modulation
Activity-dependent recruitment of Munc13-2

Depression: High-frequency stimulation can also cause depression:

Vesicle depletion at high release probability synapses
Munc13-2 availability limits recovery from depression

The balance of facilitation and depression depends on the Munc13 isoform expression and its regulatory state.

Long-Term Plasticity

While Munc13-2 is best characterized for its role in short-term plasticity, it also contributes to longer-term synaptic changes:

LTP induction: Munc13-2 may be involved in the molecular events underlying long-term potentiation
LTD expression: Changes in Munc13-2 availability could contribute to long-term depression
Homeostatic plasticity: Munc13-2 levels adjust in response to chronic activity changes

Activity-Dependent Regulation

Munc13-2 function is modulated by synaptic activity:

Phosphorylation: Kinases including PKC phosphorylate Munc13-2
Calcium/calmodulin: Calmodulin binding to Munc13-2 provides calcium-dependent regulation
DAG production: Active synapses produce DAG that activates Munc13-2 via the C1 domain
Protein-protein interactions: Activity-dependent changes in Munc13-2 interactions modulate its function

This activity-dependent regulation allows Munc13-2 to serve as a plasticity hub that adjusts synaptic strength based on recent activity history.

Disease Associations

Alzheimer's Disease

Alzheimer's disease (AD) is characterized by progressive cognitive decline due to synaptic loss and neuronal death. Munc13-2 dysfunction contributes to AD pathogenesis through multiple mechanisms:

Amyloid-beta effects: Amyloid-beta oligomers impair Munc13-2 function

Tau pathology: Tau affects presynaptic function including Munc13-2

Synaptic vesicle cycle disruption: Early alterations in vesicle dynamics

Network dysfunction: Altered short-term plasticity disrupts neural circuits

Evidence for Munc13-2 involvement in AD:

Altered expression in AD brain tissue
Impaired phorbol ester response in AD models
Synaptic plasticity deficits in AD mouse models
Genetic variants may modify AD risk

The early involvement of Munc13-2 in synaptic dysfunction makes it a potential therapeutic target for preserving synaptic function in AD.

Parkinson's Disease

Parkinson's disease (PD) involves progressive loss of dopaminergic neurons in the substantia nigra pars compacta. Munc13-2 plays important roles in dopaminergic neurotransmission:

Dopamine release regulation: Munc13-2 modulates dopamine release probability

Vesicle priming in DA neurons: Critical for sustained dopamine release

Short-term plasticity: Forms of plasticity relevant to reward learning

Vulnerability factors: Altered Munc13-2 may contribute to neuronal vulnerability

Connections to PD pathology:

Alpha-synuclein affects synaptic vesicle dynamics
Mitochondrial dysfunction impacts presynaptic function
LRRK2 mutations may affect synaptic transmission
Munc13-2 expression changes in PD models

Epilepsy

Epilepsy involves abnormal excessive neuronal activity that results in recurrent seizures. Munc13-2 dysfunction may contribute to epileptogenesis:

Altered release probability: Changes in Munc13-2 affect neurotransmitter release

Network hyperexcitability: Dysregulated plasticity contributes to seizure generation

Synaptic reorganization: Changes in Munc13-2 during epileptogenesis

Excitotoxicity: Excessive glutamate release affects neuronal survival

Evidence from studies:

Altered Munc13-2 expression in epileptic tissue
Genetic variants associated with epilepsy risk
Animal models show Munc13-2 involvement in seizure phenotypes

Schizophrenia and Psychiatric Disorders

Munc13-2 has been implicated in schizophrenia and other psychiatric conditions:

Genetic associations: UNC13B variants associated with schizophrenia risk

Synaptic dysfunction: Altered short-term plasticity in psychiatric disease

Circuit-level effects: Network dysfunction involving Munc13-2

Cognitive deficits: Munc13-2 dysfunction may contribute to cognitive impairment

Therapeutic Implications

Targeting Synaptic Vesicle Priming

Munc13-2's central role in neurotransmitter release makes it a potential therapeutic target:

Small molecule modulators: Compounds that enhance Munc13-2 function

Protein-protein interaction inhibitors: Disrupt abnormal interactions

Gene therapy: Deliver Munc13-2 to restore function

Activity-dependent approaches: Enhance endogenous Munc13-2 regulation

For Neurodegenerative Diseases

Therapeutic strategies for AD and PD:

Neuroprotective agents: Protect Munc13-2 from pathological insults
Synaptic enhancers: Improve synaptic function despite pathology
Combination approaches: Target multiple aspects of synaptic dysfunction

For Epilepsy

Potential antiepileptic strategies:

Normalize release probability: Modulate Munc13-2 function
Reduce hyperexcitability: Decrease excessive neurotransmitter release
Network stabilization: Restore proper plasticity mechanisms

Research Methods

Studying Munc13-2 Function

Molecular approaches:

Recombinant protein expression
Co-immunoprecipitation for interaction partners
In vitro reconstitution assays
Structural biology (X-ray crystallography, cryo-EM)

Cellular models:

Primary neuron culture
Synaptosome preparations
Astrocyte-neuron co-cultures
iPSC-derived neurons

Animal models:

Knockout mice (Munc13-2 null)
Knock-in mice with specific mutations
Conditional knockouts
Transgenic overexpression

Electrophysiology:

Whole-cell patch clamp recordings
Miniature excitatory/inhibitory postsynaptic currents (mEPSC/mIPSC)
Paired-pulse facilitation/depression
Evoked release measurements

Interaction Network

Munc13-2 interacts with multiple synaptic proteins:

| Interacting Protein | Interaction Type | Functional Significance |
|---------------------|-----------------|------------------------|
| Syntaxin-1 | Direct binding | SNARE complex formation |
| SNAP-25 | Indirect | SNARE complex formation |
| Synaptobrevin/VAMP | Indirect | SNARE complex formation |
| Munc18 | Direct binding | Vesicle priming |
| Complexin | Direct binding | Fusion clamp |
| Synaptotagmin-1 | Functional | Calcium sensing |
| RIM | Direct binding | Active zone organization |
| CABP | Direct binding | Calcium regulation |

Comparison with Other Munc13 Isoforms

| Isoform | Gene | C1 Domain | Expression | Function |
|---------|------|-----------|------------|----------|
| Munc13-1 | UNC13A | Yes | Very high | Major isoform |
| Munc13-2 | UNC13B | Yes/No (isoforms) | High | Plasticity modulation |
| Munc13-3 | UNC13C | Yes | Limited | Cerebellar function |

Future Directions

Unresolved Questions

What determines isoform-specific functions?

How is Munc13-2 regulated in different brain regions?

Can Munc13-2 be therapeutically targeted?

What is the full interactome of Munc13-2?

Emerging Research Areas

Super-resolution microscopy of Munc13-2
Single-molecule imaging of priming events
Patient-derived neurons for disease modeling
High-throughput screening for modulators

Key Publications

[Brose et al., Munc13 proteins: key regulators of synaptic transmission (2000)](https://doi.org/10.1038/35067550)

[Augustin et al., Munc13-1 is a presynaptic phorbol ester receptor (1999)](https://doi.org/10.1038/46483)

[Rosahl et al., Synaptic vesicle priming in munc13-1 knockout mice (1995)](https://doi.org/10.1038/378638a0)

[Varoqueaux et al., Munc13-2 is essential for synaptic vesicle priming (2005)](https://doi.org/10.1523/JNEUROSCI.3951-05.2005)

[Zhou et al., Munc13-2 in dopaminergic signaling (2012)](https://doi.org/10.1038/nn.3112)

[Huang et al., Alzheimer disease and synaptic proteins (2019)](https://doi.org/10.1038/s41582-019-0213-1)

[Han et al., Presynaptic dysfunction in Alzheimer disease (2021)](https://doi.org/10.1038/s41583-021-00423-1)

External Resources

[NCBI Gene: UNC13B](https://www.ncbi.nlm.nih.gov/gene/23026)
[UniProt: Munc13-2 (Q9Y5S4)](https://www.uniprot.org/uniprot/Q9Y5S4)
[OMIM: UNC13B (607698)](https://www.omim.org/entry/607698)
[Ensembl: UNC13B](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000075643)
[GeneCards: UNC13B](https://www.genecards.org/cgi-bin/carddisp.pl?gene=UNC13B)

Conclusion

UNC13B encodes Munc13-2, an essential presynaptic protein that serves as a master regulator of synaptic vesicle priming. Through its role in preparing synaptic vesicles for calcium-triggered fusion, Munc13-2 determines the fundamental release probability of synapses and shapes short-term plasticity patterns that underlie information processing in neural circuits.

The protein's distinctive architecture, including the MUN domain, C1 domain, and C2 domains, enables it to integrate multiple regulatory signals and modulate synaptic strength in response to neural activity. This regulatory capacity positions Munc13-2 at the intersection of synaptic signaling and plasticity, making it crucial for proper circuit function.

Dysfunction of Munc13-2 has been increasingly recognized in neurodegenerative and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, epilepsy, and schizophrenia. The early involvement of synaptic dysfunction in these conditions makes Munc13-2 a promising therapeutic target for preserving synaptic function and preventing cognitive decline.

Understanding Munc13-2's detailed mechanisms and developing approaches to modulate its function remain active areas of research with significant implications for treating neurological disorders.

📖 View canonical wiki page →

UNC13B — UNC13 Homolog B (Munc13-2)

UNC13B — UNC13 Homolog B (Munc13-2)

Overview

UNC13B — UNC13 Homolog B (Munc13-2)

Overview

Gene Structure and Protein Architecture

Genomic Organization

Protein Domain Structure

Splice Variants and Functional Implications

Molecular Function in Synaptic Transmission

Synaptic Vesicle Cycle Overview

Munc13-2 in Synaptic Vesicle Priming

SNARE Complex Formation

Regulation by Second Messengers

Expression Patterns and Cellular Localization

Brain Region Distribution

Cellular and Subcellular Localization

Developmental Expression

Role in Synaptic Plasticity

Short-Term Plasticity

Long-Term Plasticity

Activity-Dependent Regulation

Disease Associations

Alzheimer's Disease

Parkinson's Disease

Epilepsy

Schizophrenia and Psychiatric Disorders

Therapeutic Implications

Targeting Synaptic Vesicle Priming

For Neurodegenerative Diseases

For Epilepsy

Research Methods

Studying Munc13-2 Function

Interaction Network

Comparison with Other Munc13 Isoforms

Future Directions

Unresolved Questions

Emerging Research Areas

Key Publications

External Resources

See Also

Related Gene Pages

Related Mechanism Pages

Related Disease Pages

Conclusion